Methods of treating RBP4 related diseases with triazolopyridines
US11980614B2 · kind B2 · utility
0Cited by
15References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 12, 2021 |
| Grant date | May 14, 2024 |
| Priority date | — |
| Expiry date | Dec 27, 2041 |
Classification
- Technology area (CPC —)General
Abstract
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as obesity and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.